EP 1255565 A1 20021113 - PHARMACEUTICAL PREPARATIONS CONTAINING 2-PYRROLIDONE AS A SOLUBILISATION AGENT
Title (en)
PHARMACEUTICAL PREPARATIONS CONTAINING 2-PYRROLIDONE AS A SOLUBILISATION AGENT
Title (de)
PHARMAZEUTISCHE ZUBEREITUNGEN ENTHALTEND 2-PYRROLIDON ALS LÖSUNGSVERMITTLER
Title (fr)
COMPOSITIONS PHARMACEUTIQUES CONTENANT DE LA 2-PYRROLIDONE EN TANT QU'AGENT DE SOLUBILISATION
Publication
Application
Priority
- DE 10001020 A 20000113
- EP 0100081 W 20010105
Abstract (en)
[origin: WO0151089A1] The invention relates to pharmaceutical preparations containing at least one medical agent and 2-pyrrolidone as the dissolving intermediary.
IPC 1-7
IPC 8 full level
A61K 9/107 (2006.01); A61K 9/48 (2006.01); A61K 31/435 (2006.01); A61K 31/519 (2006.01); A61K 31/54 (2006.01); A61K 47/22 (2006.01)
CPC (source: EP US)
A61K 9/1075 (2013.01 - EP US); A61K 9/4858 (2013.01 - EP US); A61K 31/435 (2013.01 - EP US); A61K 31/519 (2013.01 - EP US); A61K 31/54 (2013.01 - EP US); A61K 47/22 (2013.01 - EP US); A61P 7/02 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/08 (2017.12 - EP)
Citation (search report)
See references of WO 0151089A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0151089 A1 20010719; AR 027512 A1 20030402; AU 2845401 A 20010724; EP 1255565 A1 20021113; US 2003153585 A1 20030814
DOCDB simple family (application)
EP 0100081 W 20010105; AR P010100135 A 20010112; AU 2845401 A 20010105; EP 01942307 A 20010105; US 16939602 A 20021101